0001179110-11-010019.txt : 20110623 0001179110-11-010019.hdr.sgml : 20110623 20110623104426 ACCESSION NUMBER: 0001179110-11-010019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110622 FILED AS OF DATE: 20110623 DATE AS OF CHANGE: 20110623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PENNER HARRY JR CENTRAL INDEX KEY: 0001131148 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 11926981 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494-2725 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml FORM 4 - X0303 4 2011-06-22 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001131148 PENNER HARRY JR C/O CELLDEX THERAPEUTICS, INC. 119 FOURTH AVENUE NEEDHAM MA 02494 1 0 0 0 Common Stock 2011-06-22 4 A 0 2000 A 2000 D On June 22, 2011, the Company awarded 2,000 shares of common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option Plan, subject to time-based forfeiture restrictions. Harry H. Penner, Jr. 2011-06-23